| Member Request | | |
| 275#2h | Opioid Overdose Reversal Agent Program | $8,000,000 | $8,000,000 |
| 275#4h | HB 732 Naloxone Distribution in Schools (Language Only) |
| 275#7h | HB 93 Add Alpha-gal Syndrome to List of Reportable Diseases | $20,000 | $20,000 |
| 275#8h | HB 1185 Data Sharing with Opioid Abatement Authority | $25,000 | $25,000 |
| Committee Approved | | |
| 275#1h | Naloxone Distribution in Public Schools | $0 | $100,000 |
| 275#2h | HB 93 Add Alpha-gal Syndrome to List of Reportable Diseases | $111,612 | $151,223 |
| 275#3h | HB 1185 Data Sharing with Opioid Abatement Authority | $110,000 | $25,000 |
| 275#4h | Transfer Funding for Opioid Reversal Agents to OAA | -$5,519,145 | -$5,464,145 |
| Floor Approved | | |
| 275#1h | Naloxone Distribution in Public Schools | $0 | $100,000 |
| 275#2h | HB 93 Add Alpha-gal Syndrome to List of Reportable Diseases | $111,612 | $151,223 |
| 275#3h | HB 1185 Data Sharing with Opioid Abatement Authority | $110,000 | $25,000 |
| 275#4h | Transfer Funding for Opioid Reversal Agents to OAA | -$5,519,145 | -$5,464,145 |
| Conference Report | | |
| 275#1c | Naloxone Distribution (Language Only) |
| 275#2c | Naloxone Distribution in Public Schools | $0 | $100,000 |
| 275#3c | Opioid Overdose Reversal Agent Program | $8,000,000 | $8,000,000 |